These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20408737)

  • 1. Safety of intravenous immunoglobulin treatment.
    Caress JB; Kennedy BL; Eickman KD
    Expert Opin Drug Saf; 2010 Nov; 9(6):971-9. PubMed ID: 20408737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variable immune deficiency and treatment with intravenous immunoglobulin during pregnancy.
    Brinker KA; Silk HJ
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):464-5. PubMed ID: 22626605
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent multi-organism keratoconjunctivitis manifesting as a first presentation of common variable immune deficiency (CVID).
    Ooi KG; Joshua F; Broadfoot A
    Ocul Immunol Inflamm; 2007; 15(5):403-5. PubMed ID: 17972226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute disseminated encephalomyelitis as initial clinical manifestation of common variable immunodeficiency. A case report].
    Vella FS; Simone B; Carella A; Schiraldi O; Antonaci S
    Recenti Prog Med; 2000; 91(7-8):365-7. PubMed ID: 10932921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
    Emmi L; Chiarini F
    Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse normolipemic plane xanthoma in a child with common variable immunodeficiency.
    Cambiaghi S; Boneschi V; Maffeis L; Gelmetti C
    Pediatr Dermatol; 2011; 28(1):65-6. PubMed ID: 21276061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous administration of immunoglobulin--preparations and theoretical basis of their use].
    Jankowski A
    Postepy Hig Med Dosw; 2002; 56 Suppl():5-12. PubMed ID: 12661409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency.
    Pourpak Z; Aghamohammadi A; Sedighipour L; Farhoudi A; Movahedi M; Gharagozlou M; Chavoshzadeh Z; Jadid L; Rezaei N; Moin M
    J Microbiol Immunol Infect; 2006 Apr; 39(2):114-20. PubMed ID: 16604243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration.
    Davé S; Hagan J
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):567-70. PubMed ID: 18219840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personal experience with replacement therapy with intravenous gamma globulin].
    Litzman J; Lokaj J; Stikarovská D; Mayer J; Thon V; Eibl MM
    Vnitr Lek; 1995 Nov; 41(11):759-63. PubMed ID: 8553594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of intravenous immunoglobulin in autoimmune bullous diseases.
    Chee SN; Murrell DF
    Immunol Allergy Clin North Am; 2012 May; 32(2):323-30, viii. PubMed ID: 22560145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Common variable immunodeficiency concomitant with liver cirrhosis--case report].
    Macura-Biegun A; Kowalczyk D
    Przegl Lek; 2002; 59(6):472-3. PubMed ID: 12418290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous immunoglobulin treatment in autoimmune diseases].
    Danieli MG; Calcabrini L; Marchetti A; Calabrese V; Pettinari L; Massaccesi C; Gabrielli A; Danieli G
    Recenti Prog Med; 2007 Jun; 98(6):322-6. PubMed ID: 17580523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD
    Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy.
    Nakano Y; Hayashi T; Deguchi K; Sato K; Hishikawa N; Yamashita T; Ohta Y; Takao Y; Morio T; Abe K
    J Neurol Sci; 2016 Feb; 361():9-12. PubMed ID: 26810508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal use of ivig in a patient with Behçet syndrome and common variable immunodeficiency.
    Shutty B; Garg KJ; Swender D; Chernin L; Tcheurekdjian H; Hostoffer R
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):84. PubMed ID: 22727170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.